Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...
1d
Verywell Health on MSNA New FDA-Approved Antibiotic May Help Women With Recurring UTIsIf you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...
A group of diatom species belonging to the Nitzschia genus gave up on photosynthesis and now get their carbon straight from ...
6don MSN
About 98% of lignin created as a forestry by-product from plants is discarded, but a new enzyme could be the key to ...
Digestive enzymes play a crucial role in breaking down food, enhancing nutrient absorption, and supporting overall gut health ...
The Oak Ridger on MSN4d
Got gut issues? Research at Oak Ridge National Laboratory may lead to help in the futureYou’ll likely give a fecal sample to your doctor so that your microbiome can be sequenced and available for the doctor’s medical reference.” ...
The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...
6d
The Brighterside of News on MSNHistoric Discovery Reveals New Weapon Against Drug-Resistant BacteriaThe world urgently needs new antibiotics. In 2019 alone, antibiotic-resistant bacteria killed more than 4.5 million people ...
The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
In an age where wellness and digestive health take precedence, Green Regimen Kiwi Optimize emerges as a leading choice for ...
Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results